Citadel Advisors »

Cyclerion Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Cyclerion Therapeutics (CYCN) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Cyclerion Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cyclerion Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cyclerion Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $28k 18k 1.54

More positions owned by Citadel Advisors

State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Spdr Gold Tr Gold Shs Call Option (GLD)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Amazon Call Option (AMZN)
Micron Technology Call Option (MU)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Netflix Call Option (NFLX)
Broadcom Call Option (AVGO)
Alphabet Cap Stk Cl C Call Option (GOOG)

View all positions for Citadel Advisors

Top funds holding Cyclerion Therapeutics

Siren
Geode Capital Management
Vanguard Group
Citadel Advisors
BlackRock
Vanguard Capital Management
XTX Topco
Kovack Advisors
Vanguard Fiduciary Trust
FMR
UBS Group
Tower Research Capital
Group One Trading
Advisor Group Holdings
MAI Wealth Advisors

View all funds holding Cyclerion Therapeutics